Par Drugs and Chemicals Limited (NSE:PAR)
India · Delayed Price · Currency is INR 98.77
+1.87 (1.93%)
Feb 16, 2026, 3:29 PM IST
Par Drugs and Chemicals Market Cap
Par Drugs and Chemicals has a market cap or net worth of 1.19 billion as of February 13, 2026. Its market cap has decreased by -50.64% in one year.
Market Cap
1.19B
Enterprise Value
853.76M
Revenue
1.09B
Ranking
n/a
PE Ratio
8.57
Stock Price
98.77
Market Cap Chart
Since May 16, 2019, Par Drugs and Chemicals's market cap has increased from 310.38M to 1.19B, an increase of 284.14%. That is a compound annual growth rate of 22.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.19B | -4.31% |
| Dec 31, 2025 | 1.25B | -49.09% |
| Dec 31, 2024 | 2.45B | -7.79% |
| Dec 29, 2023 | 2.65B | 42.80% |
| Dec 30, 2022 | 1.86B | -24.94% |
| Dec 31, 2021 | 2.48B | 451.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 16, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 11.10B |
| Sakar Healthcare | 9.94B |
| Sigachi Industries | 8.79B |
| Valiant Laboratories | 3.33B |
| Bafna Pharmaceuticals | 2.93B |
| Nectar Lifesciences | 2.60B |
| Brooks Laboratories | 2.23B |
| Alpa Laboratories | 1.42B |